Louise Cookson

Statistics

Publications

Citations

600

H-Index

Active since

2004

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

University College London

IQVIA (United Kingdom)

University of Oxford

Guy's Hospital

Louise Cookson is an author at GlaxoSmithKline (United Kingdom) specializing in amyloid clearance, therapeutic targeting of amyloid, and pharmacology.

Publications per year

2004–2022

Publications

Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component

Duncan Richards, Louise Cookson, Aliénor Berges et al. · New England Journal of Medicine · 2015 · 376 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Repeat doses of antibody to serum amyloid P component clear amyloid deposits in patients with systemic amyloidosis

Duncan Richards, Louise Cookson, Sharon V. Barton et al. · Science Translational Medicine · 2018 · 137 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +11

Pharmacodynamic evaluation and safety assessment of treatment with antibodies to serum amyloid P component in patients with cardiac amyloidosis: an open-label Phase 2 study and an adjunctive immuno-PET imaging study

Ashutosh Wechalekar, Gunnar Antoni, Wasfi Al Azzam et al. · BMC Cardiovascular Disorders · 2022 · 41 citations · Full text

Medicine, Nuclear Medicine, Pharmacology +15

Target Mediated Drug Disposition Model of CPHPC in Patients with Systemic Amyloidosis

Tarjinder Sahota, Aliénor Berges, Sharon V. Barton et al. · CPT Pharmacometrics & Systems Pharmacology · 2015 · 20 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

The Effect of Intravenous Infusion of Adenosine on Electrically Evoked Hyperalgesia in a Healthy Volunteer Model of Central Sensitization

Boris A. Chizh, Martin Dusch, Martin Puthawala et al. · Anesthesia & Analgesia · 2004 · 16 citations

Nursing, Pharmacology, Pharmacotherapy +16

1–5 of 6